• 1
    Ellis WJ, Chetner MP, Preston SD, Brawer MK. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol 1994; 152: 15205
  • 2
    Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 1989; 142: 6670
  • 3
    Walsh PC & Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve sparing technique. Br J Urol 1984; 56: 6947
  • 4
    Crook J, Esche B, Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology 1996; 47: 38794DOI: 10.1016/s0090-4295(99)80458-0
  • 5
    Lee HHK, Warde P, Jewett MAS. Neoadjuvant hormonal therapy in carcinoma of the prostate. BJU Int 1999; 83: 43848DOI: 10.1046/j.1464-410x.1999.00953.x
  • 6
    Braslis TC, Santa-Cruz C, Brickman AL, Soloway MS. Quality of life 12 months after radical prostatectomy. Br J Urol 1995; 75: 4851
  • 7
    Perez MA, Meyerowitz BE, Lieskovsky G, Skinner DG, Reynolds B, Skinner EC. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids. Urology 1997; 50: 7406DOI: 10.1016/s0090-4295(97)00327-0
  • 8
    Fowler FJ, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. Urology 1993; 42: 6229
  • 9
    Helgason AR, Fredickson M, Adolfsson J et al. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int J Radiat Oncol Biol 1995; 32: 339
  • 10
    Walsh PC & Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128: 4927
  • 11
    Catalona WJ & Bigg SW. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol 1990; 143: 53844
  • 12
    Cheitlin MD, Hutter AM Jr, Brindis RG et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. Circ J Am Health Assoc 1999; 99: 16877
  • 13
    Bland M. An Introduction to Medical Statistics. Oxford: Oxford University Press 1989::22104
  • 14
    Dunsmuir WD & Kirby RS. Conservation of inflatable penile prosthesis during radical prostatectomy. Br J Urol 1997; 79: 2834
  • 15
    Khoudary KP, DeWolf WC, Bruning CO III, Morgentaler A. Immediate sexual rehabilitation by simultaneous placement of penile prosthesis in patients undergoing radical prostatectomy: initial results in 50 patients. Urology 1997; 50: 3959DOI: 10.1016/s0090-4295(97)00280-x
  • 16
    Zippe CD, Kedia S, Kedia K, Nelson DR, Agarwal A. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology 1998; 52: 3636
  • 17
    Zippe CD, Jhaveri FM, Klein EA et al. Role of Viagra after radical prostatectomy. Urology 2000; 55: 2415DOI: 10.1016/s0090-4295(99)00441-0
  • 18
    Nehra A & Coldstein NA. Sildenafil citrate (Viagra) after radical prostatectomy. Urology 1999; 54: 5879DOI: 10.1016/s0090-4295(99)00283-6
  • 19
    Witherington R. Vacuum constriction device for management of erectile impotence. J Urol 1989; 141: 3202
  • 20
    Baltaci S, Aydos K, Kosar Anafarta K. Treating erectile dysfunction with a vacuum tumescence device: a retrospective analysis of acceptance and satisfaction. Br J Urol 1995; 76: 75760
  • 21
    Oakley N & Moore KTH. Vacuum devices in erectile dysfunction: indications and efficacy. Br J Urol 1998; 82: 67381
  • 22
    Hollander JB, Gonzales J, Norman T. Patient satisfaction with pharmacological erection program. Urology 1992; 39: 43941
  • 23
    Shenfeld O, Narani J, Shalhav S et al. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study. J Urol 1995; 154: 10179
  • 24
    McMahon CG, Samali R, Johnson H. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol 1999; 162: 19927
  • 25
    Marmar JL, DeBenedictis TJ, Praiss DE. The use of a vacuum constrictor device to augment a partial erection following an intracavernous injection. J Urol 1988; 140: 9759
  • 26
    Broderick GA, Allen G, McClure RD. Vacuum tumescence devices: the role of papaverine in the selection of patients. J Urol 1991; 145: 2846
  • 27
    Chen J, Godschalk MF, Katz PG, Mulligan T. Combining intracavernous injection and external vacuum as treatment for erectile dysfunction. J Urol 1995; 153: 14768


  1. Authors

J. Baniel, MD, Head of Department of Urology.

S. Israilov, MD, Senior Physician.

E. Segenreich MD, Senior Physician.

P.M. Livne, Professor, Administrative Director.


erectile dysfunction


radical retropubic prostatectomy